Teprotumumab

ATC L04AG13 · 9 markets · 10 records

Teprotumumab 9 markets · 10 records Forms

AU 2 records · 2 strengths

500 mginjectionTEPEZZA teprotumumab 500 mg injection powder vial also in US·GB unknown

Records without a stated strength · 1 TEPEZZA

US 1 records · 1 strengths

500 mginjectionTEPEZZA also in AU·GB

GB 1 records · 1 strengths

500 mginjectionTepezza 500mg powder for concentrate for solution for infusion vials also in AU·US

CA 1 records · 1 strengths

500 mgpowderTEPEZZA

SG 1 records · 1 strengths

500 mg/vialinjectionTEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/VIAL

TW 1 records · 1 strengths

Records without a stated strength · 1 TEPEZZA for injection、適目達注射劑

HK 1 records · 1 strengths

Records without a stated strength · 1 TEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 TEPEZZA

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	TW	HK	EU
500 mg injection	TEPEZZA	Tepezza 500mg powder for concentrate for solution for infusion vials	not recorded	TEPEZZA teprotumumab 500 mg injection powder vial	not recorded	not recorded	not recorded	not recorded
500 mg/vial injection	not recorded	not recorded	not recorded	not recorded	TEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500 MG/VIAL	not recorded	not recorded	not recorded
500 mg powder	not recorded	not recorded	TEPEZZA	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	TEPEZZA	not recorded	not recorded	TEPEZZA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 500MG	TEPEZZA
not disclosed injection	not recorded	not recorded	not recorded	not recorded	not recorded	TEPEZZA for 適目達注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.